海正药业(600267.SH)：产品通过美国Self-GRAS 认证

Core Points - The company, Haizheng Pharmaceutical (600267.SH), has successfully completed the Self-GRAS (Self-affirmed Generally Recognized as Safe) scientific evaluation for its product, 1,4-butanedisulfonic acid adenosylmethionine, in accordance with FDA GRAS guidelines [1] Group 1 - The product has received unanimous approval from the expert panel, marking a significant milestone for the company [1] - The successful Self-GRAS certification allows the company to enhance its product portfolio and potentially expand its market presence in the United States [1]